# QALSODY

NDC: 64406-109
Generic name: tofersen
Labeler / Manufacturer: Biogen Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRATHECAL
Marketing started: 20230425

FDA application: NDA215887

## Active ingredients

- TOFERSEN: 100 mg/15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64406-109"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64406-109
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81356b45-1cb7-4eef-88ea-e44cc18b47c5